Damae Medical

Damae Medical is a French medical imaging company based in Paris, founded in 2014. The company specializes in innovative skin imaging technology aimed at enhancing the diagnosis and treatment of skin cancer and other skin conditions. Its core product is an in vivo skin imaging device that utilizes Line-field Confocal Optical Coherence Tomography (LC-OCT) to provide non-invasive, real-time, high-resolution images of skin tissue at a cellular level. This technology allows dermatologists to perform optical biopsies and offers significant advantages over traditional histology methods. Marketed under the trademark deepLive since 2020, Damae Medical's device has gained traction in European dermatology markets, particularly in Germany, Italy, and France, and has expanded to over ten countries, including the United States and Asia. The device is designed for easy integration into various clinical settings and is primarily used by dermatologists and professionals in the cosmetics and pharmaceutical sectors. Damae Medical's skilled team focuses on developing and scaling their products while ensuring robust patent protection for their technology.

• Employees 37
• Founded 2014
• Annual Revenue $1500000
• Total Funding $7820135